Therapeutic uses for Angiotensin-(1-7)

被引：27
|
作者：
Machado-Silva, Alice [1 ]
Passos-Silva, Danielle [2 ]
Santos, Robson Augusto [2 ]
Sinisterra, Ruben Dario [3 ]
机构：
[1] Fundacao Oswaldo Cruz, CDTS, Rio De Janeiro, Brazil
[2] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Dept Quim, Inst Ciencias Exatas, Belo Horizonte, MG, Brazil
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2016年 / 26卷 / 06期
关键词：
Angiotensin (1-7); Arg0; Mas receptor; PanCyte; TXA-127; RAS; IMPROVES LIPID-METABOLISM; ORAL FORMULATION; SKELETAL-MUSCLE; ENZYME; MAS; SYSTEM; BRAIN; INFLAMMATION; INHIBITION; PEPTIDE;
D O I：
10.1080/13543776.2016.1179283
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Introduction: Angiotensin-(1-7) is a key component of the Renin-Angiotensin System, which can counter-regulate several deleterious effects caused by angiotensin II. Due to the potential for therapeutic use, several of its actions are specifically described in patents. Areas covered: In this review, the authors describe a plethora of therapeutic uses for Angiotensin-(1-7), claimed and supported by experimental evidence in patent documents and applications. Expert opinion: The clinical potential of Angiotensin-(1-7) as a therapeutic agent to treat several pathologies is evidenced by the variety of patents and clinical trials involving this peptide. Cancer treatment is one of the most advanced therapeutic areas, but clinical studies are also available in several other areas, such as cardiovascular, hematological, transplantation, surgical and medical procedures.
引用
收藏
页码：669 / 678
页数：10
相关论文
共 50 条
  • [21] Therapeutic time window for angiotensin-(1-7) in acute lung injury
    Kohse, F.
    Supe, S.
    Gembardt, F.
    Kuebler, W. M.
    Walther, T.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S66 - S66
  • [22] Angiotensin-(1-7): A novel therapeutic target for preventing cardiovascular disease
    Kumar, Gupta Jeetendra
    Krishanveer, Singh
    Kuldeep, Singh
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2022, 17 (07): : 134 - 143
  • [23] ANGIOTENSIN-(1-7) - A MEMBER OF CIRCULATING ANGIOTENSIN PEPTIDES
    KOHARA, K
    BROSNIHAN, KB
    CHAPPELL, MC
    KHOSLA, MC
    FERRARIO, CM
    HYPERTENSION, 1991, 17 (02) : 131 - 138
  • [24] Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog
    Kluskens, Leon D.
    Nelemans, S. Adriaan
    Rink, Rick
    de Vries, Louwe
    Meter-Arkema, Anita
    Wang, Yong
    Walther, Thomas
    Kuipers, Anneke
    Moll, Gert N.
    Haas, Marijke
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (03): : 849 - 854
  • [25] The therapeutic potential of angiotensin-(1-7) as a novel renin-angiotensin system mediator
    Silva, ACE
    Pinheiro, SVB
    Pereira, RM
    Ferreira, AJ
    Santos, RAS
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (05) : 603 - 609
  • [26] ANGIOTENSIN-(1-7) - A NEW HORMONE OF THE ANGIOTENSIN SYSTEM
    FERRARIO, CM
    BROSNIHAN, KB
    DIZ, DI
    JAISWAL, N
    KHOSLA, MC
    MILSTED, A
    TALLANT, EA
    HYPERTENSION, 1991, 18 (05) : S126 - S133
  • [27] Angiotensin-(1-7) and the renin-angiotensin system
    Santos, Robson A. S.
    Ferreira, Anderson J.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2007, 16 (02): : 122 - 128
  • [28] Effects of a Stabile Angiotensin-(1-7) Analogue, Cyclic Angiotensin-(1-7), on Progenitor Cell Recruitment and Cardiac Remodeling
    Pessoa, Bruno Seva
    van Veghel, Richard
    Danser, A. H. Jan
    Roks, Anton J. M.
    HYPERTENSION, 2013, 62 (03)
  • [29] Differential actions of angiotensin-(1-7) in the kidney
    Chappell, MC
    Diz, DI
    Yunis, C
    Ferrario, CM
    KIDNEY INTERNATIONAL, 1998, 54 : S3 - S6
  • [30] Megalin binds and internalizes angiotensin-(1-7)
    Gonzalez-Villalobos, R
    Klassen, RB
    Allen, PL
    Johanson, K
    Baker, CB
    Kobori, H
    Navar, LG
    Hammond, TG
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (05) : F1270 - F1275
12345